Kari Kendra
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Natural Killer Cell Therapy (UD TGFbetai NK Cells) and Temozolomide for the Treatment of Stage IV Melanoma Metastatic to the Brain (NCT05588453) | Kari Kendra | 2023-03-01 |
Track Kari Kendra automatically
Every clearance here is in the API, with alerts when new ones post.